Bangavax Covid shots: BMRC moves to resume process for clinical trials thedailystar.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thedailystar.net Daily Mail and Mail on Sunday newspapers.
Over four months have passed with no response from a government body to a local pharmaceutical company's application to conduct clinical trials for a home-grown Covid-19 vaccine. Vaccine developer Globe Biotech Ltd sent a letter to the Bangladesh Medical Research Council (BMRC) on January 17 this year to get ethical permission to conduct human trials.
Bangavax Vaccine: Permission sought for clinical trial
Staff Correspondent
Staff Correspondent
The Clinical Research Organization has asked for permission to launch a clinical trial of Covid-19 vaccine Bangavax, developed by Globe Biotech Ltd of Bangladesh.
The organisation, in an application submitted to the Bangladesh Medical Research Council (BMRC) yesterday, sought to hold first and second phase clinical trials, said chief investigator of the trial Prof Mamun Al Mahtab.
Globe Biotech got permission on January 6 from the Directorate General of Drug Administration to manufacture the doses needed in a clinical trial.
If permitted, a team of 57 researchers will decide the dosage in the first phase and examine safety and efficacy in the second.
Researchers seek permission for starting clinical trial of Globe Biotech s Covid-19 vaccine Star Online Report Star Online Report
Researchers of Clinical Research Organisation (CRO) have sought permission for starting clinical trial of Bangavax, developed by Globe Biotech Ltd.
They submitted an application to Bangladesh Medical Research Council (BMRC) seeking the permission.
The researchers have proposed first and second phase clinical trial in their proposals.
Dr Mamun Al Mahtab, Professor of Hepatology department at BSMMU; Prof Tahmina Shirin, director of IEDCR; and other officials of the research organisation and Globe Biotech Ltd were present during the submission of the proposal.
On January 6, the Directorate General of Drug Administration issued permission to produce necessary vaccine doses for clinical trial.
The government may allow human trial of three vaccine candidates in the country to enhance the possibility of getting more Covid vaccines, say officials. Health Secretary Abdul Mannan told The Daily Star yesterday that allowing clinical trial of vaccine candidates is part of the government's initiatives to find more sources of vaccines. "If any vaccine producer gives us